Macleods Pharmaceuticals Limited Ritonavir Export Data — India (DGFT 2022–2026)

Name: Macleods Pharmaceuticals Limited Ritonavir Export Records India — #12 Exporter, 4 Shipments, $160.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ritonavir

India Pharmaceutical Trade Intelligence

$340.6M84 Suppliers155 CountriesHS 30049099

ExportsIndia → BELGIUM51.5%India → INDONESIA7.8%

ImportsUNITED STATES → India$92.3K BRAZIL → India$80.0K

#1 Supplier: HETERO LABS

Macleods Pharmaceuticals Limited — Ritonavir Exporter #12 | $160.8K Trade Value | TransData Nexus | TransData Nexus

Macleods Pharmaceuticals Limited — Ritonavir Exporter Profile

Indian Pharmaceutical Exporter · #12 for Ritonavir · $160.8K export value · DGFT Verified

Macleods Pharmaceuticals Limited is the #12 Indian exporter of Ritonavir with $160.8K in export value and 4 verified shipments. Macleods Pharmaceuticals Limited holds a 0.2% market share in Ritonavir exports across 2 countries. The company exports 64 pharmaceutical products worth $589.8M across 20 therapeutic categories.

Macleods Pharmaceuticals Limited — Ritonavir Export Profile: Buyers & Destinations

Macleods Pharmaceuticals Limited Ritonavir export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Ritonavir?

Country	Value	Shipments	Share
BELGIUM	$9.9M	199	33.2%
SOUTH AFRICA	$3.4M	67	11.2%
UNITED STATES	$2.9M	57	9.5%
KENYA	$2.4M	48	8.0%

Who Are the Top Buyers of Ritonavir from India?

Buyer	Country	Value	Orders
NATIONAL MEDICAL STORES	UGANDA	$1.1M	22
EXPEDITORS INTERNATIONAL NV	BELGIUM	$650.0K	13
PFIZER SER CO BV	BELGIUM	$450.0K	9
MINISTRY OF HEALTH AND CHILD CARE	ZIMBABWE	$350.0K	7
M S TO THE ORDER OF ESSERS LSP I	BELGIUM	$300.0K	6
SAI PHARMA CO LTD	THAILAND	$300.0K	6
DIGECITSS -MINISTERIO DE SALUD PUBL	DOMINICAN REPUBLIC	$200.0K	4
EMBASSY OF THE UNITED STATES OF AME	TANZANIA	$150.0K	3
CENTRAL PHARMACEUTICAL CPC1. JSC	VIETNAM	$100.0K	2
CENTRAL PHARMACEUTICAL CPC1.JSC	VIETNAM	$100.0K	2

India's Ritonavir is purchased by 525 buyers worldwide. The top buyer is NATIONAL MEDICAL STORES (UGANDA), followed by EXPEDITORS INTERNATIONAL NV and PFIZER SER CO BV.

How Does Macleods Pharmaceuticals Limited Compare to Nearest Ritonavir Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	LIVEALTH BIOPHARMA PRIVATE LIMITED	$200.0K	4	2	$50.0K
11	AAGAMA EXPORTS LLP	$193.0K	5	1	$38.6K
12	MACLEODS PHARMACEUTICALS LIMITED ★	$160.8K	4	2	$40.2K

Macleods Pharmaceuticals Limited ranks #12 among 84 Indian Ritonavir exporters. Average shipment value of $40.2K compared to the market average of $823.4K. The closest competitors by value are LIVEALTH BIOPHARMA PRIVATE LIMITED and AAGAMA EXPORTS LLP.

Which Indian Ports Ship Ritonavir Exports?

Port	Shipments	% Share
SAHAR AIR	335	21.5%
SAHAR AIR CARGO ACC (INBOM4)	281	18.1%
HYDERABAD ACC (INHYD4)	217	14.0%
HYDERABAD AIR	123	7.9%
Bombay Air	87	5.6%
NHAVA SHEVA SEA (INNSA1)	58	3.7%
DELHI AIR CARGO ACC (INDEL4)	48	3.1%
HYDERABAD ICD	47	3.0%

Geopolitical & Trade Policy Impact on Macleods Pharmaceuticals Limited's Ritonavir Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Macleods Pharmaceuticals. The Israel-Iran tensions have escalated security risks in the Red Sea and Strait of Hormuz, leading to increased shipping costs and extended transit times. Major carriers have rerouted vessels around the Cape of Good Hope, adding 10–20 days to shipments and raising freight rates by 40–50% on key India–Europe routes. (livemint.com)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. However, potential U.S. tariffs on Indian pharmaceutical imports pose a significant risk. A 25% tariff could render many low-margin generic drugs unprofitable, compelling companies to scale back operations or exit certain product segments, thereby exacerbating drug shortages in the U.S. (cfo.economictimes.indiatimes.com)

The recent India–European Union Free Trade Agreement, signed in January 2026, offers a favorable development by eliminating tariffs on most pharmaceutical products. This agreement is expected to enhance the competitiveness of Indian exporters in the EU market, providing a counterbalance to challenges in other regions. (en.wikipedia.org)

Macleods Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a cornerstone for Indian pharmaceutical exporters. Macleods Pharmaceuticals' recent recalls in the U.S. market, including the Famciclovir tablet recall due to contamination, highlight the critical need for stringent adherence to Good Manufacturing Practices (GMP). Such incidents can tarnish a company's reputation and impede market access. (pharma.economictimes.indiatimes.com)

The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates robust serialization and traceability measures. Indian exporters must invest in advanced compliance systems to meet these requirements, ensuring product integrity and sustaining export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ritonavir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Macleods Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 155+ countries, 525+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ritonavir

Ritonavir

Macleods Pharmaceuticals Limited — Ritonavir Exporter Profile

Macleods Pharmaceuticals Limited — Ritonavir Export Profile: Buyers & Destinations

Where Does India Export Ritonavir?

Who Are the Top Buyers of Ritonavir from India?

What Is India's Total Ritonavir Export Value and How Much Does Macleods Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Macleods Pharmaceuticals Limited's Ritonavir Exports?

How Does Macleods Pharmaceuticals Limited Compare to Other Indian Ritonavir Exporters?

Regulatory Requirements: Exporting Ritonavir to Key Markets

South Africa — SAHPRA

United States — FDA

How Does Macleods Pharmaceuticals Limited Compare to Nearest Ritonavir Exporters?

Which Indian Ports Ship Ritonavir Exports?

Geopolitical & Trade Policy Impact on Macleods Pharmaceuticals Limited's Ritonavir Exports

Macleods Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Macleods Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ritonavir Export Data from Macleods Pharmaceuticals Limited

Ritonavir Stats

Company Overview

Top Products by Macleods Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source